ロード中...

Advertisement

Lavie Bio Appoints Guri Oron As CEO

RTTNews | 1106日前

Lavie Bio Appoints Guri Oron As CEO

(RTTNews) - Lavie Bio Ltd., a subsidiary of Evogene Ltd. (EVGN), announced Wednesday the appointment of Guri Oron as Chief Executive Officer of Lavie Bio, effective as of September 18, 2022.

Oron is a veteran executive in multi-disciplinary, deep-tech organizations, leading medical device and ag-tech companies from inception to market. He brings over 20 years of extensive experience at various early-stage technology companies both in Israel and internationally, most recently at Viridix Ltd., an ag-tech company focused on precision irrigation.

Previously, Oron was the CEO for seven years at BlueWind Medical Ltd., an active implantable medical device company. Prior to that, he served as CEO and co-founder at Cybotech Ltd. and as VP R&D at BrainsGate Ltd.

タグ: EVGN

read more

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Swiss agricultural innovation firm Syngenta Crop Protection and Israel's Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (EVGN), announced Tuesday an agreement for the discovery and development of new biological insecticidal solutions.

RTTNews | 582日前

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

Lavie Bio Ltd., a subsidiary of ag-biologicals company Evogene Ltd. (EVGN) announced on Monday a licensing agreement with ag innovation company Corteva Inc. (CTVA), that grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.

RTTNews | 800日前

Bay Street Likely To Open Slightly Higher

Bay Street Likely To Open Slightly Higher

Modestly higher futures point to a slightly positive start for the Canadian market on Wednesday. However, uncertainty about further interest rate cuts by the Fed this year, and worries about valuations may render the mood cautious and limit market's upside.

RTTNews | 16分前

U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

The U.S. dollar continued to be strong against other major currencies in the European session on Wednesday, weighed down by Federal Reserve Chairman Jerome Powell's comments that equity prices are fairly highly valued by many measures.

RTTNews | 33分前

FTSE 100 Modestly Lower In Cautious Trade

FTSE 100 Modestly Lower In Cautious Trade

U.K. stocks are turning in a mixed performance in cautious trade on Wednesday. Uncertainty about Fed interest rate outlook, and on comments from Fed Chair Jerome Powell's warning that equity valuations are stretched.

RTTNews | 54分前

CAC 40 Drifts Lower On Valuation Concerns, Rate Uncertainty

CAC 40 Drifts Lower On Valuation Concerns, Rate Uncertainty

French stocks are showing some weakness on Wednesday amid apprehensions about the outlook for Fed rate cuts, and Fed Chair Jerome Powell's comments that equity valuations are high.

RTTNews | 1時34分前

Sensex, Nifty Extend Declines For Fourth Day

Sensex, Nifty Extend Declines For Fourth Day

Indian shares ended lower for a fourth day running on Wednesday, with trade-related concerns, rising oil prices and continued selling by foreign investors keeping investors on edge.

RTTNews | 2時8分前

U.S. Dollar Rises Against Majors

U.S. Dollar Rises Against Majors

The U.S. dollar strengthened against other major currencies in the European session on Wednesday.

RTTNews | 2時20分前

利用規約 | プライバシー | サイトマップ | Site Map Calendar

© 2025 Myfxbook Ltd。全著作権所有。

ハイリスクの警告：外国為替取引にはハイリスクが伴っているので、全ての人に適しているとは限りません。レバレッジは、追加のリスクと損失のエクスポージャーを生み出します。外国為替取引を決定する前に、あなたの投資目的、経験レベル、リスク許容度を慎重に検討してください。初期投資の一部及びその全ての失う可能性があるので、必要最低限以上のお金は投資しないでください。外国為替取引に関連するリスクについては、自分自身で学んで質問がある場合は独立した財務や税務顧問に質問してください。データと情報は全て'そのままの形'で提供されます。それらは情報提供のみを目的としており、取引目的やアドバイスを目的としたものではありません。過去の実績は、将来の結果を示すものではありません。